Patents by Inventor Hannah Vaughan

Hannah Vaughan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transcriptionally targeted and CpG-free plasmid for theranostic gene therapy
    Patent number: 11697804
    Abstract: A DNA plasmid useful for diagnostic and therapeutic gene therapy is disclosed. Improvements to gene therapy methods known in the art are provided to ensure cancer-targeting, high efficacy, and long durability of expression. The DNA plasmid is combined with compositions of polymeric nanoparticles for non-viral gene therapy to treat cancer, including hepatocellular carcinoma and prostate cancer.
    Type: Grant
    Filed: October 1, 2019
    Date of Patent: July 11, 2023
    Assignee: The Johns Hopkins University
    Inventors: Jordan J. Green, Martin G. Pomper, Camila Gadens Zamboni, Hannah Vaughan, Il Minn
  • TRANSCRIPTIONALLY TARGETED AND CPG-FREE PLASMID FOR THERANOSTIC GENE THERAPY
    Publication number: 20200140831
    Abstract: A DNA plasmid useful for diagnostic and therapeutic gene therapy is disclosed. Improvements to gene therapy methods known in the art are provided to ensure cancer-targeting, high efficacy, and long durability of expression. The DNA plasmid is combined with compositions of polymeric nanoparticles for non-viral gene therapy to treat cancer, including hepatocellular carcinoma and prostate cancer.
    Type: Application
    Filed: October 1, 2019
    Publication date: May 7, 2020
    Inventors: Jordan J. Green, Martin G. Pomper, Camila Gadens Zamboni, Hannah Vaughan, Il Minn